TCL Archive Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial October 26, 2012
TCL Archive Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction” September 11, 1998
TCL Archive ASCO Calls On NCI To Double Funding For Cooperative Group Clinical Trials December 31, 2010